Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Griet Van Lancker

Awards & Distinctions

13 Results

2024

Pharmacokinetic and pharmacodynamic assessments of atogepant in healthy male adults : results from phase 1 studies

Ramesh BoinpallyMarleen DepréGriet Van LanckerMarissa F DockendorfPhung BondiskeyJean-Francois DenefTom ReyndersCatherine Zhou MatthewsK Chris MinJialin Xu et al.

A2 Journal Article in CEPHALALGIA REPORTS

2023

First-in-human, phase Ia/b, dose-escalation/expansion study of KRAS G12C inhibitor BI 1823911, as monotherapy and combined with anticancer therapies, in patients (pts) with advanced or metastatic solid tumours harbouring a KRAS G12C mutation

J. HeymachN. KoteckiH. PrenenG. AlonsoC.R. LindsayM. BarveC. ThamerS. Eigenbrod-GieseM.A. MarottiGriet Van Lancker

Single ascending doses of REGN7999, a monoclonal antibody inhibitor of TMPRSS6, increase serum hepcidin and cause deep, sustained reductions in serum iron in healthy human volunteers

Sylvie RotteyNikhil SinghEmily Labriola-TompkinsHeinrich E LobKusha MohammadiHazem HassanLorna FarrellySwati DuggalHarvey ChinSarah Hatsell et al.

2021

A phase 1B multi-tumor cohort study of cabozantinib plus atezolizumab in advanced solid tumors : results of the triple-negative breast cancer, ovarian cancer, and endometrial cancer cohorts

Ira WinerAkhila WimalasinghamJoaquina BarandaArmando SantoroKristen SpencerCapucine BaldiniLinda DuskaVivek SubbiahSandip PatelPolina Khrizman et al.

Phase I dose escalation study of MCLA-145, a bispecific antibody targeting CD137 and PD-L1 in solid tumors

H. PrenenC. KyiGriet Van LanckerS.P. PatelD. MittagA. WeaverK. BolV. StalbovskayaJ. PuliniG. Zhou et al.

2020

An update on the management of metastatic clear-cell renal cell carcinoma : the BSMO expert panel recommendations

Brant DelafontaineC. De BackerB. BeuselinckP. DebruyneL. D’HondtC. GennigensT. GilC. VulstekeN. Martinez-ChanzaA. Verbiest et al.

A2 Journal Article in BELGIAN JOURNAL OF MEDICAL ONCOLOGY

2019

Doravirine and the potential for CYP3A-mediated drug-drug interactions

SG KhaliliehKL YeeRI SanchezL FanMS AndersonM SuraT LaethemS RasmussenLucas Van BortelGriet Van Lancker et al.

A1 Journal Article in ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Switchability of gabapentin formulations : a randomized trial to assess bioequivalence between Neurontin and Gabasandoz on the individual subject level

Griet Van LanckerLucas Van BortelBrant DelafontaineKoen BousseryEleonora SwartAbdel ChahbouniJan Van BocxlaerPieter Colin

A1 Journal Article in CLINICAL PHARMACOLOGY & THERAPEUTICS

2017

KH176 under development for rare mitochondrial disease : a first in man randomized controlled clinical trial in healthy male volunteers

Saskia KoeneEdwin SpaansLucas Van BortelGriet Van LanckerBrant DelafontaineFabio BadiliniJulien BeyrathJan Smeitink

A1 Journal Article in ORPHANET JOURNAL OF RARE DISEASES

2016

Virussen in de behandeling van kanker : oncolytische virotherapie

Brant DelafontaineGriet Van LanckerLucas Van BortelSylvie Rottey

A2 Journal Article in TIJDSCHRIFT VOOR GENEESKUNDE

2015

Evaluation of a Cerebral-Blood-Volume (CBV) pharmaco-MRI (phMRI) assay utilizing low (0.1mg/70kg) and high (0.2mg/70kg) dose buprenorphine infusion and a novel USPIO contrast agent (Ferumoxytol) in healthy human subjects

Richard BaumgartnerArie StruykJeff EvelhochCynthia GarganoFrancheska Colon GonzalezHaiying LiuRuben DeclercqHans VerheydenIngeborg HeirmanHANS DE PLA et al.

2014

Exploratory clinical development

Lucas Van BortelF VanmolkotGriet Van Lancker

Bookchapter in Handboek farmaceutische geneeskunde

2011

Pharmacokinetics (PK) and Pharmacodynamics (PD) of a new direct thrombin inhibitor (DPOC-4088) after single oral doses of two prolonged release formulations in healthy male subjects

Lucas Van BortelGriet Van LanckerHENRI VANDEN BAVIEREWillem HettemaEdwin SpaansSankar RamakrishnanVenkatesan ElumalaiSuryakumar JayanthiStephane E Allard